GS1's Ulrike Kreysa on A Global Outlook to Unique Device Identifiers for Medical Devices

Add bookmark

GS1, received on 17 December, 2013 accreditation by the U.S. Food and Drug Administration (FDA) as issuing agency for unique device identifiers (UDIs).  In this interview, Ulrike Kreysa Vice President of Healthcare for GS1 global office, speaks to Andrea Charles from Pharma IQ about the importance of aligning master data, how the FDA final rule for UDIs is impacting the landscape and what's next for European regulation. Pharma IQ: The FDA final rule for UDIs came out last year. How...
To continue reading this story get free access

RECOMMENDED